| Cutaneous T-Cell Lymphoma |
1 |
1 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.95 |
| Skin Cancer |
0 |
0.97 |
| Lymphoma |
0 |
0.83 |
| Biologic Therapy |
0 |
0.99 |
| Immunotherapy |
0 |
0.28 |
| Toxicology |
0 |
0.26 |
| Visual Impairment |
0 |
0.26 |
| Capillary |
0 |
0.18 |
| Impairment |
0 |
0.18 |
| Pruritus |
0 |
0.18 |
| Care and Maintenance of Vision |
0 |
0.14 |
| Interleukin-2 |
0 |
0.13 |
| Aminotransferase |
0 |
0.09 |
| Cancer |
0 |
0.09 |
| Dermatoses |
0 |
0.09 |
| Edema |
0 |
0.09 |
| Fatigue |
0 |
0.09 |
| Fever |
0 |
0.09 |
| Hemoglobin |
0 |
0.09 |
| Interleukin |
0 |
0.09 |
| Nausea |
0 |
0.09 |
| Pain |
0 |
0.09 |
| Receptors |
0 |
0.09 |
| Refractory |
0 |
0.09 |
| Tumor |
0 |
0.09 |
| Constipation |
0 |
0.07 |
| Pain Management |
0 |
0.07 |